Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline Sclerotherapy in Hidradenitis Suppurativa
NCT02805595Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Aug 2016
- Primary completion
- Nov 2022
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of hypertonic saline in hidradenitis suppurativa (HS), sponsored by Beth Israel Deaconess Medical Center. Started Aug 2016; status: completed.
02
Drugs
hypertonic saline
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT02805595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805595.